Global HIV Diagnostics Market Size, Status and Forecast 2024-2031

Report ID: 1013109 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Consumables
        1.2.3 Assay, Kits and Reagents
        1.2.4 Other Consumables
        1.2.5 Instruments
        1.2.6 Software and Services
    1.3 Market by Application
        1.3.1 Global HIV Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Antibody Tests
        1.3.3 Viral Load Tests
        1.3.4 CD4 Tests
        1.3.5 Tests for Early Infant Diagnosis
        1.3.6 Tests for Viral Identification
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global HIV Diagnostics Market Perspective (2016-2027)
    2.2 HIV Diagnostics Growth Trends by Regions
        2.2.1 HIV Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 HIV Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 HIV Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 HIV Diagnostics Industry Dynamic
        2.3.1 HIV Diagnostics Market Trends
        2.3.2 HIV Diagnostics Market Drivers
        2.3.3 HIV Diagnostics Market Challenges
        2.3.4 HIV Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top HIV Diagnostics Players by Revenue
        3.1.1 Global Top HIV Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by HIV Diagnostics Revenue
    3.4 Global HIV Diagnostics Market Concentration Ratio
        3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2020
    3.5 HIV Diagnostics Key Players Head office and Area Served
    3.6 Key Players HIV Diagnostics Product Solution and Service
    3.7 Date of Enter into HIV Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Diagnostics Breakdown Data by Type
    4.1 Global HIV Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global HIV Diagnostics Forecasted Market Size by Type (2022-2027)

5 HIV Diagnostics Breakdown Data by Application
    5.1 Global HIV Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global HIV Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America HIV Diagnostics Market Size (2016-2027)
    6.2 North America HIV Diagnostics Market Size by Type
        6.2.1 North America HIV Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America HIV Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America HIV Diagnostics Market Size by Type (2016-2027)
    6.3 North America HIV Diagnostics Market Size by Application
        6.3.1 North America HIV Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America HIV Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America HIV Diagnostics Market Size by Application (2016-2027)
    6.4 North America HIV Diagnostics Market Size by Country
        6.4.1 North America HIV Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America HIV Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe HIV Diagnostics Market Size (2016-2027)
    7.2 Europe HIV Diagnostics Market Size by Type
        7.2.1 Europe HIV Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe HIV Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe HIV Diagnostics Market Size by Type (2016-2027)
    7.3 Europe HIV Diagnostics Market Size by Application
        7.3.1 Europe HIV Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe HIV Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe HIV Diagnostics Market Size by Application (2016-2027)
    7.4 Europe HIV Diagnostics Market Size by Country
        7.4.1 Europe HIV Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe HIV Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific HIV Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific HIV Diagnostics Market Size by Type
        8.2.1 Asia-Pacific HIV Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific HIV Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific HIV Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific HIV Diagnostics Market Size by Application
        8.3.1 Asia-Pacific HIV Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific HIV Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific HIV Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific HIV Diagnostics Market Size by Region
        8.4.1 Asia-Pacific HIV Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific HIV Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America HIV Diagnostics Market Size (2016-2027)
    9.2 Latin America HIV Diagnostics Market Size by Type
        9.2.1 Latin America HIV Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America HIV Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America HIV Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America HIV Diagnostics Market Size by Application
        9.3.1 Latin America HIV Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America HIV Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America HIV Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America HIV Diagnostics Market Size by Country
        9.4.1 Latin America HIV Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America HIV Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa HIV Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa HIV Diagnostics Market Size by Type
        10.2.1 Middle East & Africa HIV Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa HIV Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa HIV Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa HIV Diagnostics Market Size by Application
        10.3.1 Middle East & Africa HIV Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa HIV Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa HIV Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa HIV Diagnostics Market Size by Country
        10.4.1 Middle East & Africa HIV Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa HIV Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott HIV Diagnostics Introduction
        11.1.4 Abbott Revenue in HIV Diagnostics Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Abbott Healthcare
        11.2.1 Abbott Healthcare Company Details
        11.2.2 Abbott Healthcare Business Overview
        11.2.3 Abbott Healthcare HIV Diagnostics Introduction
        11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2016-2021)
        11.2.5 Abbott Healthcare Recent Development
    11.3 Abbvie Inc.
        11.3.1 Abbvie Inc. Company Details
        11.3.2 Abbvie Inc. Business Overview
        11.3.3 Abbvie Inc. HIV Diagnostics Introduction
        11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2016-2021)
        11.3.5 Abbvie Inc. Recent Development
    11.4 Brsitol-Myers Squibb
        11.4.1 Brsitol-Myers Squibb Company Details
        11.4.2 Brsitol-Myers Squibb Business Overview
        11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction
        11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2016-2021)
        11.4.5 Brsitol-Myers Squibb Recent Development
    11.5 Janssen Therapeutics
        11.5.1 Janssen Therapeutics Company Details
        11.5.2 Janssen Therapeutics Business Overview
        11.5.3 Janssen Therapeutics HIV Diagnostics Introduction
        11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2016-2021)
        11.5.5 Janssen Therapeutics Recent Development
    11.6 Gilead Sciences
        11.6.1 Gilead Sciences Company Details
        11.6.2 Gilead Sciences Business Overview
        11.6.3 Gilead Sciences HIV Diagnostics Introduction
        11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2016-2021)
        11.6.5 Gilead Sciences Recent Development
    11.7 Merck & Co. Inc
        11.7.1 Merck & Co. Inc Company Details
        11.7.2 Merck & Co. Inc Business Overview
        11.7.3 Merck & Co. Inc HIV Diagnostics Introduction
        11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2016-2021)
        11.7.5 Merck & Co. Inc Recent Development
    11.8 VIIV Healthcare
        11.8.1 VIIV Healthcare Company Details
        11.8.2 VIIV Healthcare Business Overview
        11.8.3 VIIV Healthcare HIV Diagnostics Introduction
        11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2016-2021)
        11.8.5 VIIV Healthcare Recent Development
    11.9 BD Biosciences
        11.9.1 BD Biosciences Company Details
        11.9.2 BD Biosciences Business Overview
        11.9.3 BD Biosciences HIV Diagnostics Introduction
        11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2016-2021)
        11.9.5 BD Biosciences Recent Development
    11.10 Beckman Coulter
        11.10.1 Beckman Coulter Company Details
        11.10.2 Beckman Coulter Business Overview
        11.10.3 Beckman Coulter HIV Diagnostics Introduction
        11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2016-2021)
        11.10.5 Beckman Coulter Recent Development
    11.11 Partec
        11.11.1 Partec Company Details
        11.11.2 Partec Business Overview
        11.11.3 Partec HIV Diagnostics Introduction
        11.11.4 Partec Revenue in HIV Diagnostics Business (2016-2021)
        11.11.5 Partec Recent Development
    11.12 Sysmex
        11.12.1 Sysmex Company Details
        11.12.2 Sysmex Business Overview
        11.12.3 Sysmex HIV Diagnostics Introduction
        11.12.4 Sysmex Revenue in HIV Diagnostics Business (2016-2021)
        11.12.5 Sysmex Recent Development
    11.13 Apogee Flow Systems
        11.13.1 Apogee Flow Systems Company Details
        11.13.2 Apogee Flow Systems Business Overview
        11.13.3 Apogee Flow Systems HIV Diagnostics Introduction
        11.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2016-2021)
        11.13.5 Apogee Flow Systems Recent Development
    11.14 PointCare Technologies Inc.
        11.14.1 PointCare Technologies Inc. Company Details
        11.14.2 PointCare Technologies Inc. Business Overview
        11.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction
        11.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2016-2021)
        11.14.5 PointCare Technologies Inc. Recent Development
    11.15 Zyomyx Inc.
        11.15.1 Zyomyx Inc. Company Details
        11.15.2 Zyomyx Inc. Business Overview
        11.15.3 Zyomyx Inc. HIV Diagnostics Introduction
        11.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2016-2021)
        11.15.5 Zyomyx Inc. Recent Development
    11.16 Mylan inc.
        11.16.1 Mylan inc. Company Details
        11.16.2 Mylan inc. Business Overview
        11.16.3 Mylan inc. HIV Diagnostics Introduction
        11.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2016-2021)
        11.16.5 Mylan inc. Recent Development
    11.17 Roche Diagnostics
        11.17.1 Roche Diagnostics Company Details
        11.17.2 Roche Diagnostics Business Overview
        11.17.3 Roche Diagnostics HIV Diagnostics Introduction
        11.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2016-2021)
        11.17.5 Roche Diagnostics Recent Development
    11.18 Siemens Healthcare
        11.18.1 Siemens Healthcare Company Details
        11.18.2 Siemens Healthcare Business Overview
        11.18.3 Siemens Healthcare HIV Diagnostics Introduction
        11.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2016-2021)
        11.18.5 Siemens Healthcare Recent Development
    11.18 Qiagen
        .1 Qiagen Company Details
        .2 Qiagen Business Overview
        .3 Qiagen HIV Diagnostics Introduction
        .4 Qiagen Revenue in HIV Diagnostics Business (2016-2021)
        .5 Qiagen Recent Development
    11.20 BioMerieux
        11.20.1 BioMerieux Company Details
        11.20.2 BioMerieux Business Overview
        11.20.3 BioMerieux HIV Diagnostics Introduction
        11.20.4 BioMerieux Revenue in HIV Diagnostics Business (2016-2021)
        11.20.5 BioMerieux Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global HIV Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Consumables
    Table 3. Key Players of Assay, Kits and Reagents
    Table 4. Key Players of Other Consumables
    Table 5. Key Players of Instruments
    Table 6. Key Players of Software and Services
    Table 7. Global HIV Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global HIV Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global HIV Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global HIV Diagnostics Market Share by Regions (2016-2021)
    Table 11. Global HIV Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global HIV Diagnostics Market Share by Regions (2022-2027)
    Table 13. HIV Diagnostics Market Trends
    Table 14. HIV Diagnostics Market Drivers
    Table 15. HIV Diagnostics Market Challenges
    Table 16. HIV Diagnostics Market Restraints
    Table 17. Global HIV Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global HIV Diagnostics Market Share by Players (2016-2021)
    Table 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnostics as of 2020)
    Table 20. Ranking of Global Top HIV Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by HIV Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players HIV Diagnostics Product Solution and Service
    Table 24. Date of Enter into HIV Diagnostics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global HIV Diagnostics Revenue Market Share by Type (2016-2021)
    Table 28. Global HIV Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global HIV Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global HIV Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global HIV Diagnostics Revenue Market Share by Application (2016-2021)
    Table 32. Global HIV Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global HIV Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific HIV Diagnostics Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific HIV Diagnostics Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Abbott Company Details
    Table 65. Abbott Business Overview
    Table 66. Abbott HIV Diagnostics Product
    Table 67. Abbott Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 68. Abbott Recent Development
    Table 69. Abbott Healthcare Company Details
    Table 70. Abbott Healthcare Business Overview
    Table 71. Abbott Healthcare HIV Diagnostics Product
    Table 72. Abbott Healthcare Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 73. Abbott Healthcare Recent Development
    Table 74. Abbvie Inc. Company Details
    Table 75. Abbvie Inc. Business Overview
    Table 76. Abbvie Inc. HIV Diagnostics Product
    Table 77. Abbvie Inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 78. Abbvie Inc. Recent Development
    Table 79. Brsitol-Myers Squibb Company Details
    Table 80. Brsitol-Myers Squibb Business Overview
    Table 81. Brsitol-Myers Squibb HIV Diagnostics Product
    Table 82. Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 83. Brsitol-Myers Squibb Recent Development
    Table 84. Janssen Therapeutics Company Details
    Table 85. Janssen Therapeutics Business Overview
    Table 86. Janssen Therapeutics HIV Diagnostics Product
    Table 87. Janssen Therapeutics Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 88. Janssen Therapeutics Recent Development
    Table 89. Gilead Sciences Company Details
    Table 90. Gilead Sciences Business Overview
    Table 91. Gilead Sciences HIV Diagnostics Product
    Table 92. Gilead Sciences Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 93. Gilead Sciences Recent Development
    Table 94. Merck & Co. Inc Company Details
    Table 95. Merck & Co. Inc Business Overview
    Table 96. Merck & Co. Inc HIV Diagnostics Product
    Table 97. Merck & Co. Inc Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 98. Merck & Co. Inc Recent Development
    Table 99. VIIV Healthcare Company Details
    Table 100. VIIV Healthcare Business Overview
    Table 101. VIIV Healthcare Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 102. VIIV Healthcare Recent Development
    Table 103. BD Biosciences Company Details
    Table 104. BD Biosciences Business Overview
    Table 105. BD Biosciences HIV Diagnostics Product
    Table 106. BD Biosciences Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 107. BD Biosciences Recent Development
    Table 108. Beckman Coulter Company Details
    Table 109. Beckman Coulter Business Overview
    Table 110. Beckman Coulter HIV Diagnostics Product
    Table 111. Beckman Coulter Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 112. Beckman Coulter Recent Development
    Table 113. Partec Company Details
    Table 114. Partec Business Overview
    Table 115. Partec HIV Diagnostics Product
    Table 116. Partec Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 117. Partec Recent Development
    Table 118. Sysmex Company Details
    Table 119. Sysmex Business Overview
    Table 120. Sysmex HIV Diagnostics Product
    Table 121. Sysmex Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 122. Sysmex Recent Development
    Table 123. Apogee Flow Systems Company Details
    Table 124. Apogee Flow Systems Business Overview
    Table 125. Apogee Flow Systems HIV Diagnostics Product
    Table 126. Apogee Flow Systems Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 127. Apogee Flow Systems Recent Development
    Table 128. PointCare Technologies Inc. Company Details
    Table 129. PointCare Technologies Inc. Business Overview
    Table 130. PointCare Technologies Inc. HIV Diagnostics Product
    Table 131. PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 132. PointCare Technologies Inc. Recent Development
    Table 133. Zyomyx Inc. Company Details
    Table 134. Zyomyx Inc. Business Overview
    Table 135. Zyomyx Inc. HIV Diagnostics Product
    Table 136. Zyomyx Inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 137. Zyomyx Inc. Recent Development
    Table 138. Mylan inc. Company Details
    Table 139. Mylan inc. Business Overview
    Table 140. Mylan inc. HIV Diagnostics Product
    Table 141. Mylan inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 142. Mylan inc. Recent Development
    Table 143. Roche Diagnostics Company Details
    Table 144. Roche Diagnostics Business Overview
    Table 145. Roche Diagnostics HIV Diagnostics Product
    Table 146. Roche Diagnostics Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 147. Roche Diagnostics Recent Development
    Table 148. Siemens Healthcare Company Details
    Table 149. Siemens Healthcare Business Overview
    Table 150. Siemens Healthcare HIV Diagnostics Product
    Table 151. Siemens Healthcare Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 152. Siemens Healthcare Recent Development
    Table 153. Qiagen Company Details
    Table 154. Qiagen Business Overview
    Table 155. Qiagen HIV Diagnostics Product
    Table 156. Qiagen Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 157. Qiagen Recent Development
    Table 158. BioMerieux Company Details
    Table 159. BioMerieux Business Overview
    Table 160. BioMerieux HIV Diagnostics Product
    Table 161. BioMerieux Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
    Table 162. BioMerieux Recent Development
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HIV Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. Consumables Features
    Figure 3. Assay, Kits and Reagents Features
    Figure 4. Other Consumables Features
    Figure 5. Instruments Features
    Figure 6. Software and Services Features
    Figure 7. Global HIV Diagnostics Market Share by Application: 2020 VS 2027
    Figure 8. Antibody Tests Case Studies
    Figure 9. Viral Load Tests Case Studies
    Figure 10. CD4 Tests Case Studies
    Figure 11. Tests for Early Infant Diagnosis Case Studies
    Figure 12. Tests for Viral Identification Case Studies
    Figure 13. HIV Diagnostics Report Years Considered
    Figure 14. Global HIV Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global HIV Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global HIV Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 17. Global HIV Diagnostics Market Share by Regions (2022-2027)
    Figure 18. Global HIV Diagnostics Market Share by Players in 2020
    Figure 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnostics as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by HIV Diagnostics Revenue in 2020
    Figure 21. Global HIV Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 22. Global HIV Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 23. North America HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America HIV Diagnostics Market Share by Type (2016-2027)
    Figure 25. North America HIV Diagnostics Market Share by Application (2016-2027)
    Figure 26. North America HIV Diagnostics Market Share by Country (2016-2027)
    Figure 27. United States HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe HIV Diagnostics Market Share by Type (2016-2027)
    Figure 31. Europe HIV Diagnostics Market Share by Application (2016-2027)
    Figure 32. Europe HIV Diagnostics Market Share by Country (2016-2027)
    Figure 33. Germany HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific HIV Diagnostics Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific HIV Diagnostics Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific HIV Diagnostics Market Share by Region (2016-2027)
    Figure 43. China HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America HIV Diagnostics Market Share by Type (2016-2027)
    Figure 51. Latin America HIV Diagnostics Market Share by Application (2016-2027)
    Figure 52. Latin America HIV Diagnostics Market Share by Country (2016-2027)
    Figure 53. Mexico HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa HIV Diagnostics Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa HIV Diagnostics Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa HIV Diagnostics Market Share by Country (2016-2027)
    Figure 59. Turkey HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Abbott Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 63. Abbott Healthcare Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 64. Abbvie Inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 65. Brsitol-Myers Squibb Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 66. Janssen Therapeutics Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 67. Gilead Sciences Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 68. Merck & Co. Inc Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 69. VIIV Healthcare Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 70. BD Biosciences Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 71. Beckman Coulter Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 72. Partec Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 73. Sysmex Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 74. Apogee Flow Systems Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 75. PointCare Technologies Inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 76. Zyomyx Inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 77. Mylan inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 78. Roche Diagnostics Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 79. Siemens Healthcare Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 80. Qiagen Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 81. BioMerieux Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Frequently Asked Questions
HIV Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
HIV Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
HIV Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports